Multiple Organ Manifestation in Neonatal Lupus Erythematous (Report of Two Cases)

Authors: Lubis A., Widayanti R., Hikmah Z., Endaryanto A., Harsono A., Harianto A., Etika R., Handayani D. K., Sampurna M.

Abstract:

Neonatal lupus erythematous (NLE) is a rare disease marked by clinical characteristic and specific maternal autoantibody. Many cutaneous, cardiac, liver, and hematological manifestations could happen with affect of one organ or multiple. In this case, both babies were premature, low birth weight (LBW), small for gestational age (SGA) and born through caesarean section from a systemic lupus erythematous (SLE) mother. In the first case, we found a baby girl with dyspnea and grunting. Chest X ray showed respiratory distress syndrome (RDS) great I and echocardiography showed small atrial septal defect (ASD) and ventricular septal defect (VSD). She also developed anemia, thrombocytopenia, elevated C-reactive protein, hypoalbuminemia, increasing coagulation factors, hyperbilirubinemia, and positive blood culture of Klebsiella pneumonia. Anti-Ro/SSA and Anti-nRNP/sm were positive. Intravenous fluid, antibiotic, transfusion of blood, thrombocyte concentrate, and fresh frozen plasma were given. The second baby, male presented with necrotic tissue on the left ear and skin rashes, erythematous macula, athropic scarring, hyperpigmentation on all of his body with various size and facial haemorrhage. He also suffered from thrombocytopenia, mild elevated transaminase enzyme, hyperbilirubinemia, anti-Ro/SSA was positive. Intravenous fluid, methyprednisolone, intravenous immunoglobulin (IVIG), blood, and thrombocyte concentrate transfution were given. Two cases of neonatal lupus erythematous had been presented. Diagnosis based on clinical presentation and maternal auto antibody on neonate. Organ involvement in NLE can occur as single or multiple manifestations.

Keywords: Neonatus lupus erythematous, maternal autoantibody, clinical characteristic.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1093496

References:

[1] Lee L.A., Neonatal lupus erythematous: clinical findings and pathogenesis. J Investig Dermatol Symp Proc., 2004, 9, pp. 52-56.
[2] Frey M.N, Loppi A.E.E, Garbin G.C, Furian R.D, Bau A.E.K., Congenital and neonatal lupus erythematous: two case reports. An Bras Dermatol., 2012, vol. 87(4), pp. 625-628.
[3] Cimaz R., Spence D.L, Hornberger L, Earl D. Silverman E.D., Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-ro autoantibodies. J Pediatr., 2003, 142, pp. 678-683.
[4] Medical record data. Department of child health school of medicine dr. sutomo hospital data Surabaya. 2012-2013, unpublished.
[5] Buyon JP., Anti-Ro/SSA antibodies and congenital heart block: necesarry but not sufficient. Arthritis Rheum., 2001, 44, pp. 1723-1727.
[6] Buyon J.P, Lindsley C.B, Silverman E.D. Neonatal lupus erythematous. In James T. Cassidy, Rose E. Petty, Ronald M. Laxr, Carol B. Lindsley eds. Pediatric rheumatology 6th Edition. Philadelphia: WB Saunders Company, 2011, pp. 361-373.
[7] Liu J, Yang Y, Lin Y, Chiang B. Clinical characteristic of neonatal lupus erythematous., J Microbiol Imunol Infect., 2001, 34, pp. 265-268.
[8] Shahian M, KhorsraviA, Anbardar M.H. Early cholestasis in neonatal lupus erythematous. Annals of Saudi Medicine., 2011, vol. 31(1), pp. 80-82.
[9] Khamastha M. Systemic lupus erythematous and pregnancy. Best Pract Res Clin Rheumatol., 2006, vol. 20(4), pp. 685-694.
[10] Mok C.C, Wong R.W.S, Pregnancy in systemic lupus erythematous. Postgrad Med J., 2001, 77, pp. 157-165.
[11] Tincani A., et al. Impact in utero environtment on the offspring of lupus patients. Lupus., 2006, 15, pp. 801-807.
[12] Hornberger L.K., Al Rajaa N. Spectrum of cardiac involvement in neonatal lupus. Scan J Immunol., 2010, 72, pp. 189–197.
[13] Capone C, Buyon J.P, Friedman D.M, Frishman W.H. cardiac manifestations of neonatal lupus: a review of autoantibody associated congenital heart block and its impact in an adult population. Cardiol Rev., 2012, vol. 20(2), pp. 72–76.
[14] Wisuthsarewong W, Soongswang J, Chantorn R.Neonatal lupus erythematosus: clinical character, investigation, and outcome. Pediatric Dermatol., 2011, vol. 28 (2), pp. 115–21.
[15] Gasparello-Almeida R, Feitosa-Oliviera S.K. Neontal lupus erythematous: an acquired autoimmune disorder and its cutaneous manifestations. IMAJ., 2008, 1, pp. 473-474.
[16] Lee L. Cutaneous lupus in infancy and childhood. Lupus., 2010, 19, 1112-1117.
[17] Frankovich J, Sandborg C, Barnes P, Hintz S, Chakravarty E. Neonatal lupus and related autoimmune disorders on infants. AAP., 2008, 9, pp. 206-217.
[18] Pain C, Beresford M.W, Neonatal lupus syndrome. J Paed., 2007, 17, 223-227.
[19] Osman M.E.F. Childhood immune thrombocytopenia: clinical presentation and management Sudanese Journal of Paediatrics., 2012, vol. 12(1), pp. 27-35.
[20] Barlow M, Lehman H.K. Intravenous immune serum globulin (IVIG) therapy in patients with antibody immune deficiency. In Donald Y.M Leung, Hugh A. Sampson, Raif Geha, Stanley J. Szeeler eds. Pediatric Allergy 2nd Edition. Philadelphia: WB Saunders Company, 2011, pp. 187-195.
[21] Silverman E.D. Non cardiac manifestation of neonatal lupus erythematous. Scandinavian Journal of Immunology., 2010, vol. 72(3), pp. 223-225.
[22] Hon K.L, Leung K.C. Neonatal lupus erythematous. Autoimmune Diseases., 2012, pp. 1-5.